Clinique des maladies lipidiques de Quebec

Québec G1V 4W2

1 studies enrolling now · 5 studies all time

What they study most

Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Dyslipidemia, Hypertriglyceridemia, Obesity or Overweight, Type 2 Diabetes Mellitus, Type2 Diabetes

Studies at this site

• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Recruiting now
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis — Stopped early
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) — Completed